5th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation

22 - 23 October 2012, Athens, Greece.
Cancer is a natural phenomenon and as such it should be amenable to mathematical and computational description. Clinically driven complex multiscale cancer models can produce rather realistic spatio-temporal simulations of concrete clinical interventions such as radio-chemotherapy applied to individual patients.

Clinical data processing procedures and computer technologies play an important role in this context. Following clinical adaptation and validation within the framework of clinico-genomic trials, models are expected to enhance individualized treatment optimization. The latter constitutes the long term goal of the emergent scientific, technological and medical discipline of in silico oncology.

Treatment optimization is to be achieved through experimentation in silico i.e. on the computer. Moreover, provision of insight into tumour dynamics and optimization of clinical trial design and interpretation constitute short- and mid-term goals of this new domain. Researchers working either in the area of in silico oncology or in the broader cancer research domain yet with an interest in computational oncology are invited to submit short papers.

The workshop is meant to be an excellent opportunity for both shaping and advancing the discipline.

Organizing Committee

  • G. Stamatakos, PhD, ICCS - National Technical University of Athens (GR), General Chair
  • Ν. Graf, MD, University Clinic of Saarland (DE)
  • K. Marias, PhD, Foundation for Research and Technology, Hellas (GR)
  • M. Akay, PhD, University of Houston (USA)
  • R.Radhakrishnan, PhD, University of Pennsylvania (USA)
  • D. Dionysiou, PhD, ICCS - National Technical University of Athens (GR)
  • V. Sakkalis, PhD, Foundation for Research and Technology - Hellas (GR)
  • N. Uzunoglu, PhD, ICCS - National Technical University of Athens (GR)

Important Dates
Paper submissions due: September 1, 2012.
Notification of acceptance: September 21, 2012. Camera ready papers due: September 30, 2012.

This year the 5th International Αdvanced Research Workshop on In Silico Oncology and Cancer Investigation will also be the TUMOR project workshop.

The TUMOR project aims at developing a European clinically oriented semantic-layered cancer digital model repository from existing EU projects that will be interoperable with the US grid enabled semantic-layered digital model repository platform at CViT.org (Center for the Development of a Virtual Tumor, Massachusetts General Hospital (MGH), Boston, USA) which is NIH/NCI-caGRID compatible.

For further information, please visit:
http://www.5th-iarwisoci.iccs.ntua.gr

Most Popular Now

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...